CLINICAL_TRIALS trial_result · 2023-08-03

Clinical Trial Update: A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF) [Phase 3]

Phase 3 trial assessing the effect of ELX/TEZ/IVA on glucose tolerance in participants with cystic fibrosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2023-08-03